SMITH LEY S 4
4 · TITAN PHARMACEUTICALS INC · Filed Jan 5, 2012
Insider Transaction Report
Form 4
TITAN PHARMACEUTICALS INCTTNP.OB
SMITH LEY S
Director
Transactions
- Award
Option to Purchase Common Stock
2012-01-03+35,000→ 35,000 totalExercise: $1.15Exp: 2022-01-03→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]These options vest in 12 equal monthly installments beginning on the grant date.